Literature DB >> 12370503

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.

Patricia Price1, Grant Morahan, Dexing Huang, Emma Stone, Karey Y M Cheong, Alison Castley, Marina Rodgers, Meredith Q McIntyre, Lawrence J Abraham, Martyn A French.   

Abstract

OBJECTIVE: To further elucidate the immunopathogenesis of immune restoration diseases (IRD) in HIV patients responding to antiretroviral therapy and determine whether IRD associated with different opportunistic pathogens involve distinct immunopathological mechanisms.
DESIGN: DNA samples from patients with a range of IRD were typed for polymorphic loci in genes encoding immune-mediators.
METHODS: PCR-restriction fragment length polymorphism assays were used to type loci in the and genes. Alleles of a microsatellite in the CD30 promoter were determined by capillary electrophoresis.
RESULTS: Only 8% of patients with IRD associated with a herpesvirus infection carried IL12B-3'UTR*2, compared with 42-54% of patients with other or no IRD. Patients with IRD arising from mycobacterial infection rarely carried IL6-174*C (36% versus 61-71%) and never carried TNFA-308*2 (0% versus 23-52%). TNFA-308*2 was carried by 52% of patients who experienced IRD associated with a herpesvirus infection, as several patients with exacerbations of cytomegalovirus retinitis carried this as part of a HLA-A2,B44 haplotype. Polymorphisms in and showed no distinct patterns.
CONCLUSIONS: Distinct cytokine-mediated mechanisms contribute to IRD initiated by herpesvirus and mycobacterial infections. Copyright 2002 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370503     DOI: 10.1097/00002030-200210180-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  44 in total

Review 1.  HIV and asthma, is there an association?

Authors:  Jessica A Kynyk; Jonathan P Parsons; Michael F Para; Susan L Koletar; Philip T Diaz; John G Mastronarde
Journal:  Respir Med       Date:  2012-01-27       Impact factor: 3.415

2.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors:  Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

3.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.

Authors:  Luc Kestens; Nabila Seddiki; Paul R Bohjanen
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

Review 4.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 6.  Update on progressive multifocal leukoencephalopathy.

Authors:  Israel Steiner; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

7.  Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome.

Authors:  Daniel L Barber; Bruno B Andrade; Cortez McBerry; Irini Sereti; Alan Sher
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

Review 8.  Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy.

Authors:  Sarah M Kranick; Avindra Nath
Journal:  Continuum (Minneap Minn)       Date:  2012-12

9.  [Severe aseptic leucoencephalopathy. Manifested as immune reconstitution inflammatory syndrome in Caucasian and African patients].

Authors:  A Ringelstein; C Oelschlaeger; G Arendt; C Mathys; R Dziewas; T Niederstadt; D Reichelt; M Hasselblatt; I W Husstedt; A Saleh
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

10.  Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Authors:  Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Journal:  BMC Med Genet       Date:  2010-04-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.